| 3′ UTR | 3′ Untranslated region |
| AKT | AKT serine/threonine kinase |
| BRAF | B-Raf Proto-Oncogene, Serine/Threonine Kinase |
| BC | Breast cancer |
| CAS | Caspase |
| CDH1 | E cadherin |
| CDH2 | N Cadherin |
| CRC | Colorectal cancer |
| CTNNB1 | Beta catenin |
| EGFR | Epidermal growth factor receptor |
| EMT | Epithelial–mesenchymal transition |
| ERBB2 | Human epidermal growth factor receptor 2 |
| ERK | Extracellular signal-regulated kinase |
| FASCN1 | Fascin actin-bundling protein 1 |
| FOXP3 | Forkhead box O3 |
| FUS | Fused in sarcoma |
| GC | Gastric cancer |
| GSK3B | Glycogen synthase kinase 3 beta |
| IGF1R | insulin-like growth factor 1 receptor |
| LAHS | Lymphoma-associated hemophagocytic syndrome |
| LC | Lung cancer |
| LC3B | Microtubule-associated protein 1 light chain 3 |
| MAML | Mastermind-like 1 |
| MAPK | Mitogen-Activated Protein Kinase |
| MiRISC | miRNA-induced silencing complex |
| MMP | Matrix metalloproteinases |
| PC | Prostate cancer |
| MIR133A | MicroRNA 133A |
| PI3K | Phosphatidylinositol 3-kinase |
| SOX2 | SRY-box transcription factor 2 |
| VEGF | Vascular endothelial growth factor |
| VIM | Vimentin |
| YES1 | YES proto-oncogene 1 |